Last deal

$50.M

Amount

Post-IPO Debt

Stage

30.04.2024

Date

6

all rounds

$125.6M

Total amount

General

About Company
TriSalus Life Sciences develops infusion systems for interventional radiology.

Industry

Sector :

Subsector :

founded date

01.01.2009

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Debt

IPO status

Private

Description

Based in Westminster, Colorado, TriSalus Life Sciences is an immunotherapy company that aims to improve the lives of patients with liver and pancreatic tumors. The company's organ-specific platform integrates innovative drug delivery technology and novel therapeutics to overcome the challenges of immune response suppression and ineffective drug delivery caused by high intratumoral pressure.
Contacts

Phone number

Social url